Compugen (CGEN) Total Non-Current Liabilities (2009 - 2026)

Compugen recorded quarterly Total Non-Current Liabilities of $28.5 million in Q1 2026, down 8.95% quarter-over-quarter from $31.3 million in Q4 2025.

Compugen's Total Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $28.5 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $28.5 million; the TTM figure through Mar 2026 stood at $28.5 million (changed N/A YoY), while the FY2025 annual figure was $31.3 million, down 21.67% from the prior year.
  • Total Non-Current Liabilities came in at $28.5 million for Q1 2026 at Compugen, down from $31.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $39.9 million in Q4 2024 to a low of $4.6 million in Q4 2022.
  • A 5-year average of $26.7 million and a median of $29.5 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities slumped 45.34% in 2022 and jumped 544.72% in 2023, its largest moves.
  • Compugen's Total Non-Current Liabilities stood at $4.6 million in 2022, then surged by 544.72% to $29.5 million in 2023, then jumped by 35.28% to $39.9 million in 2024, then slipped by 21.67% to $31.3 million in 2025, then decreased by 8.95% to $28.5 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $28.5 million, $31.3 million, and $39.9 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 11.03 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 42,980.09
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.28 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.87 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 7.32 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Compugen 234.03 Mn 142.28 Mn 352,000.00 28.47 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 28.47 Mn
Dec 31, 2025 31.27 Mn
Sep 30, 2025 33.74 Mn
Jun 30, 2025 35.69 Mn
Mar 31, 2025 37.34 Mn
Dec 31, 2024 39.92 Mn
Sep 30, 2024 35.27 Mn
Jun 30, 2024 27.06 Mn
Mar 31, 2024 29.40 Mn
Dec 31, 2023 29.51 Mn
Sep 30, 2023 4.01 Mn
Jun 30, 2023 4.25 Mn
Mar 31, 2023 4.39 Mn
Dec 31, 2022 4.58 Mn
Sep 30, 2022 4.78 Mn
Jun 30, 2022 5.94 Mn
Mar 31, 2022 7.08 Mn
Dec 31, 2021 8.37 Mn
Sep 30, 2021 7.22 Mn
Jun 30, 2021 7.55 Mn
Mar 31, 2021 7.74 Mn
Dec 31, 2020 8.01 Mn
Sep 30, 2020 8.20 Mn
Jun 30, 2020 8.39 Mn
Mar 31, 2020 8.33 Mn
Dec 31, 2019 8.62 Mn
Sep 30, 2019 8.74 Mn
Jun 30, 2019 9.45 Mn
Mar 31, 2019 9.84 Mn
Dec 31, 2018 5.95 Mn
Sep 30, 2018 3.20 Mn
Jun 30, 2018 2.99 Mn
Mar 31, 2018 3.16 Mn
Dec 31, 2017 3.26 Mn
Sep 30, 2017 3.24 Mn
Jun 30, 2017 3.33 Mn
Mar 31, 2017 3.16 Mn
Dec 31, 2016 2.88 Mn
Sep 30, 2016 2.90 Mn
Jun 30, 2016 2.79 Mn
Mar 31, 2016 2.74 Mn
Dec 31, 2015 2.56 Mn
Sep 30, 2015 2.52 Mn
Jun 30, 2015 2.59 Mn
Mar 31, 2015 2.29 Mn
Dec 31, 2014 2.28 Mn
Sep 30, 2014 3.21 Mn
Jun 30, 2014 16.60 Mn
Mar 31, 2014 17.42 Mn
Dec 31, 2013 17.08 Mn
Sep 30, 2013 19.15 Mn
Jun 30, 2013 14.22 Mn
Mar 31, 2013 10.10 Mn
Dec 31, 2012 9.85 Mn
Sep 30, 2012 7.62 Mn
Jun 30, 2012 6.56 Mn
Mar 31, 2012 9.15 Mn
Dec 31, 2011 8.08 Mn
Sep 30, 2011 4.94 Mn
Jun 30, 2011 5.11 Mn
Mar 31, 2011 5.91 Mn
Dec 31, 2010 5.73 Mn
Sep 30, 2010 1.60 Mn
Dec 31, 2009 1.32 Mn